OrthoView showcases version 5.2

TriMed Staff | | Health Imaging | Artificial Intelligence
OrthoView demonstrated its upgraded web-deployed version 5.2 software, an improved version of its orthopedic digital planning and templating software, at the recent 2008 RSNA conference in Chicago.

OrthoView 5.2 is available via PACS providers and offers a quicker start up time and an improved integration as well as added clinical features and additional template-handling capabilities, the company said.

OrthoView 5.2 contains a number of new clinical features in addition to improving overall performance that include new tools for the Spine module such as the Nash Moe Grading Guide; Thoracic Trunk Shift Wizard; a combined Pelvic Incidence, Sacral Slope and Pelvic Tilt Wizard, according to OrthoView.

TriMed Staff

Related Content

Most popular radiology video interviews on Health Imaging
RamSoft and Alpha Nodus partner to streamline imaging prior authorization processes
GE HealthCare launches new AI-enabled automated breast ultrasound system
AI quantifies breast arterial calcifications on mammograms
AI 'not safe' to be implemented as a solo reader for breast cancer screening exams
What radiologists think about using ChatGPT and AI in breast imaging

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.